Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) EPS (Basic) (2021 - 2025)

Senti Biosciences has reported EPS (Basic) over the past 5 years, most recently at -$0.48 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 22.58% year-over-year to -$0.48; the TTM value through Dec 2025 reached -$3.14, up 73.9%, while the annual FY2025 figure was -$2.73, 77.31% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.48 at Senti Biosciences, up from -$0.69 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $0.09 in Q4 2022 and troughed at -$8.24 in Q3 2023.
  • A 5-year average of -$2.32 and a median of -$1.37 in 2021 define the central range for EPS (Basic).
  • On a YoY basis, EPS (Basic) climbed as much as 106.8% in 2022 and fell as far as 1578847.37% in 2022.
  • Year by year, EPS (Basic) stood at -$1.32 in 2021, then surged by 106.8% to $0.09 in 2022, then tumbled by 4755.56% to -$4.19 in 2023, then soared by 85.2% to -$0.62 in 2024, then rose by 22.58% to -$0.48 in 2025.
  • Business Quant data shows EPS (Basic) for SNTI at -$0.48 in Q4 2025, -$0.69 in Q3 2025, and -$0.56 in Q2 2025.